Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis

Yi‐Wei Lin(First Affiliated Hospital Zhejiang University), Liping Xie(First Affiliated Hospital Zhejiang University), Chenhe Zhou(Second Affiliated Hospital of Zhejiang University), Kai Yang(Harbin Medical University), Huafeng Chen, Qinan Mao(First Affiliated Hospital Zhejiang University), Xiangyi Zheng(Tianjin University)
Irish Journal of Medical Science (1971 -)
March 11, 2011
10.1007/s11845-011-0692-6
Cited by 52

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188